Table 2.

Risk ratio for NS relapse (Generalized estimating equation Poisson regression)

	for NS relapses
	Risk ratio	95% Confidence interval
The post-vaccination period (days 0 to  + 30)	1.02	0.64–1.62
The post-vaccination period (days  + 31 to  + 60)	1.3	0.86–1.98
The post-vaccination period (days  + 61 to  + 90)	1.16	0.74–1.80
The post-vaccination period (days  + 91 to  + 120)	1.14	0.73–1.77
The post-vaccination period (days  + 121 to  + 180)	1.09	0.77–1.54
On Immunosuppressants (reference: no immunosuppressants)	0.86	0.62–1.20
On RTX (reference: no RTX)	1.11	0.50–2.49
On PSL (reference: no PSL)	3.01	2.18–4.17
Flu infection (reference: no infection)	2.38	0.81–6.99

NS Nephrotic syndrome, RTX Rituximab, PSL prednisolone